47 related articles for article (PubMed ID: 17954023)
1. High frequency of level II-V lymph node involvement in RET/PTC positive papillary thyroid carcinoma.
Wang YL; Zhang RM; Luo ZW; Wu Y; Du X; Wang ZY; Zhu YX; Li DS; Ji QH
Eur J Surg Oncol; 2008 Jan; 34(1):77-81. PubMed ID: 17954023
[TBL] [Abstract][Full Text] [Related]
2. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
[TBL] [Abstract][Full Text] [Related]
3. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
4. [Gene rearrangement analysis of papillary thyroid carcinoma].
Wang YL; Wang JC; Li DS; Zhu YX; Wu Y; Ji QH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 42(12):929-33. PubMed ID: 18335752
[TBL] [Abstract][Full Text] [Related]
5. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract][Full Text] [Related]
6. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
[TBL] [Abstract][Full Text] [Related]
7. RET/PTC Rearrangement--a link between Hashimoto's thyroiditis and thyroid cancer...or not.
Nikiforov YE
J Clin Endocrinol Metab; 2006 Jun; 91(6):2040-2. PubMed ID: 16757533
[No Abstract] [Full Text] [Related]
8. An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid.
Hunt JP; Buchmann LO; Wang L; Abraham D
Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1141-5. PubMed ID: 22106241
[TBL] [Abstract][Full Text] [Related]
9. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells.
Ameziane-El-Hassani R; Boufraqech M; Lagente-Chevallier O; Weyemi U; Talbot M; Métivier D; Courtin F; Bidart JM; El Mzibri M; Schlumberger M; Dupuy C
Cancer Res; 2010 May; 70(10):4123-32. PubMed ID: 20424115
[TBL] [Abstract][Full Text] [Related]
10. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality.
Salter KD; Andersen PE; Cohen JI; Schuff KG; Lester L; Shindo ML; Sauer D; Gross ND
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):692-6. PubMed ID: 20644065
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma.
Koo BS; Yoon YH; Kim JM; Choi EC; Lim YC
Ann Surg Oncol; 2009 May; 16(5):1344-7. PubMed ID: 19224280
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Baena JA; Simó R; Mesa J
Histopathology; 2007 Jan; 50(2):225-31. PubMed ID: 17222251
[TBL] [Abstract][Full Text] [Related]
13. [
Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216
[No Abstract] [Full Text] [Related]
14. Real-time quantitative analysis of E-cadherin expression in ret/PTC-1-activated thyroid neoplasms.
Smyth P; Sheils O; Finn S; Martin C; O'Leary J; Sweeney EC
Int J Surg Pathol; 2001 Oct; 9(4):265-72. PubMed ID: 12574841
[TBL] [Abstract][Full Text] [Related]
15. ret/PTC-1 expression alters the immunoprofile of thyroid follicular cells.
Denning K; Smyth P; Cahill S; Li J; Flavin R; Aherne S; O' Leary JJ; Sheils O
Mol Cancer; 2008 May; 7():44. PubMed ID: 18505566
[TBL] [Abstract][Full Text] [Related]
16. Hürthle cell tumors: using molecular techniques to define a novel classification system.
Belchetz G; Cheung CC; Freeman J; Rosen IB; Witterick IJ; Asa SL
Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):237-40. PubMed ID: 11886336
[TBL] [Abstract][Full Text] [Related]
17. Indicators of multifocality in papillary thyroid carcinoma concurrent with Hashimoto's thyroiditis.
Dong S; Xie XJ; Xia Q; Wu YJ
Am J Cancer Res; 2019; 9(8):1786-1795. PubMed ID: 31497359
[TBL] [Abstract][Full Text] [Related]
18. Formation of carcinogenic chromosomal rearrangements in human thyroid cells after induction of double-strand DNA breaks by restriction endonucleases.
Evdokimova V; Gandhi M; Rayapureddi J; Stringer JR; Nikiforov YE
Endocr Relat Cancer; 2012 Jun; 19(3):271-81. PubMed ID: 22323563
[TBL] [Abstract][Full Text] [Related]
19. The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto's Thyroiditis.
Yeo MK; Bae JS; Lee S; Kim MH; Lim DJ; Lee YS; Jung CK
Int J Endocrinol; 2015; 2015():456027. PubMed ID: 25983754
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ultrasonography and pathology features between children and adolescents with papillary thyroid carcinoma.
Jie Y; Ruan J; Cai Y; Luo M; Liu R
Heliyon; 2023 Jan; 9(1):e12828. PubMed ID: 36704282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
